Metrics as of 10/16/2026, 08:43 AM (Berlin time), refresh in progress.
Abingdon Health Plc
Established in 2008 and based in York, United Kingdom, Abingdon Health Plc is a global entity dedicated to the creation, production, and worldwide distribution of diagnostic instruments. Their product line features the AbC-19 Rapid Test, a fast-acting diagnostic for COVID-19 IgG antibodies, alongside various nucleic…
1D
+0.0%
1W
-16.3%
1M
-16.3%
6M
+0.0%
YTD
+40.6%
1Y
+44.0%
2Y
-5.3%
5Y
-82.8%
10Y
–
Next earnings date
18/11/2026 (in 32 days)
Volatility around earnings
~0% stronger price swings than usual
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 13/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BearishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
P/E
-15
P/B
5.82
EV/EBITDA
-9.95
RETURN ON EQUITY
3.6%
NET MARGIN
3.3%
DEBT/EQUITY
0.22
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
95.2%
FLOAT SHARES
240,700,629
AVG. DAILY VOLUME (30D)
124,378
Abingdon Health Plc is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in United Kingdom.
The CEO is Christopher William Hand, the company employs around 113 people.
The IPO was on 15/12/2020; the stock trades on LSE under the ticker ABDX.L.
The next earnings date is 18/11/2026.
Around past earnings, price swings were roughly 0% stronger than usual.
No, Abingdon Health currently does not pay a dividend.
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and IDEXX Laboratories.
Clicking "Analyze stock" lets five strategies assess Abingdon Health against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.